012 — RiVive, Balfaxar, Xdemvy
Here is information on the latest US FDA approvals, the week of July 24 – July 28, 2023. RiVive OTC Approval for Opioid OverdoseThe FDA has approved RiVive, a 3…
011 — Vanflyta®, BeyfortusTM, CyfendusTM, Ycanth™
Here is information on the latest US FDA approvals, the week of July 17 – July 21, 2023. Please subscribe, rate and review this podcast. Thank you!Vanflyta® for FLT3-ITD+ AMLThe…
010 — Opill®, Leqvio®, Dengue Vaccine
Here is information on the latest US FDA approvals, the week of July 10 – July 14, 2023. Please subscribe, rate and review this podcast. Thank you! Opill® First…
005 — Prevymis, Vevye, Leqembi, Nirsevimab, Restylane Eyelight
Here is information on the latest US FDA approvals, the week of June 5 – June 9, 2023. Please subscribe, rate and review. Thank you! PREVYMIS (letermovir) CMV in high-risk…
004 — Abrysvo and Select ASCO News
Here is information on the latest US FDA approvals, the week of May 29 – June 2, 2023. Please subscribe, rate and review. Thank you!RSV vaccine for older adultsThe FDA…
003 — Inpefa, Paxlovid, TheLinkBCI, Xacduro, Brixadi, Opvee
Here is information on the latest US FDA approvals, the week of May 22 – May 26, 2023. Please subscribe, rate and review. Thank you!Inpefa (sotagliflozin) for heart failureThe FDA…
002 — BionicPancreas, Vyjuvek, Epkinly, Miebo, KryptorTest, Rinvoq, RSVpreF, BCI
Here is information on the latest US FDA approvals, the week of May 15- May 19, 2023. Please subscribe, rate and review. Thank you!iLet Bionic PancreasThe FDA has approved components…